GALMED PHARMACEUTICALS LTD
(M47238106)
ファンドの報告 GALMED PHARMACEUTICALS LTD 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| 683 Capital Management LLC | 1,350,000 | $9,923k | Jun 30, 2019 | Aug 14, 2019 | |
| VIVO Capital LLC | 971,337 | $7,139k | Jun 30, 2019 | Aug 13, 2019 | |
| Nantahala Capital Management LLC | 879,200 | $6,559k | Jun 30, 2019 | Aug 14, 2019 | |
| IBEX Investors LLC | 807,400 | $5,934k | Jun 30, 2019 | Jul 29, 2019 | |
| Baker BROS Advisors LP | 215,594 | $1,585k | Jun 30, 2019 | Aug 14, 2019 | |
| Premier Asset Management LLC | 77,904 | $572k | Jun 30, 2019 | Aug 7, 2019 | |
| The Rock Creek Group LP | 57,201 | $420k | Jun 30, 2019 | Aug 14, 2019 | |
| Renaissance Technologies LLC | 32,300 | $237k | Jun 30, 2019 | Aug 12, 2019 |